Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13226
Anghami
ANGH
$33.6M
| $17.2K | ﹤0.01% |
2,155
-1,016
| -32% | -$7.93K |
2024 Q2
2 quarters
|
|
13227
CALL
Arrow Financial
AROW
$696M
| $17.2K | ﹤0.01% |
+600
| New | +$18.3K |
2024 Q4
0 quarters
|
|
13228
PUT
National Bank Holdings
NBHC
$1.69B
| $17.2K | ﹤0.01% |
+400
| New | +$18.1K |
2024 Q4
0 quarters
|
|
|
KLRS
13229
CALL
Kalaris Therapeutics
KLRS
$69.7M
| $17.2K | ﹤0.01% |
1,783
+1,135
| +175% | +$17.2K |
2022 Q2
10 quarters
|
|
13230
PUT
Atossa Therapeutics
ATOS
$25.1M
| $17.2K | ﹤0.01% |
1,213
+640
| +112% | +$12.5K |
2020 Q2
18 quarters
|
|
13231
CALL
GCM Grosvenor
GCMG
$807M
| $17.2K | ﹤0.01% |
+1,400
| New | +$16.6K |
2024 Q4
0 quarters
|
|
13232
PUT
Haleon
HLN
$39B
| $17.2K | ﹤0.01% |
1,800
+1,700
| +1,700% | +$16.6K |
2022 Q3
9 quarters
|
|
13233
PUT
iShares MSCI Malaysia ETF
EWM
$285M
| $17.2K | ﹤0.01% |
700
+200
| +40% | +$4.99K |
2024 Q3
1 quarter
|
|
13234
PUT
Heritage Financial
HFWA
$1.15B
| $17.1K | ﹤0.01% |
700
-1,300
| -65% | -$31.6K |
2023 Q1
7 quarters
|
|
13235
CALL
CVB Financial
CVBF
$3.91B
| $17.1K | ﹤0.01% |
800
| – | – |
2022 Q4
8 quarters
|
|
|
YJ
13236
Yunji
YJ
$7.98M
| $17.1K | ﹤0.01% |
+10,621
| New | +$19.9K |
2024 Q4
0 quarters
|
|
13237
CALL
8x8 Inc
EGHT
$318M
| $17.1K | ﹤0.01% |
6,400
+700
| +12% | +$1.8K |
2017 Q4
28 quarters
|
|
13238
bioAffinity Technologies
BIAFW
$545K
| $17.1K | ﹤0.01% |
50,245
+11,065
| +28% | +$9.33K |
2023 Q1
7 quarters
|
|
13239
CALL
Celcuity
CELC
$3.5B
| $17K | ﹤0.01% |
1,300
-4,600
| -78% | -$64.9K |
2022 Q4
8 quarters
|
|
|
NUVB.WS
13240
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $17K | ﹤0.01% |
73,959
-1,750
| -2% | -$226 |
2021 Q1
15 quarters
|
|
13241
CALL
Kforce
KFRC
$923M
| $17K | ﹤0.01% |
300
+100
| +50% | +$5.81K |
2022 Q4
8 quarters
|
|
|
13242
PUT
Kforce
KFRC
$923M
| $17K | ﹤0.01% |
300
-200
| -40% | -$11.6K |
2022 Q3
9 quarters
|
|
13243
PUT
OFS Capital
OFS
$56.1M
| $16.9K | ﹤0.01% |
2,100
+1,200
| +133% | +$9.84K |
2022 Q3
9 quarters
|
|
13244
PUT
Enviri
NVRI
$576M
| $16.9K | ﹤0.01% |
2,200
-46,300
| -95% | -$386K |
2022 Q4
8 quarters
|
|
13245
CALL
RAVE Restaurant Group
RAVE
$33.5M
| $16.9K | ﹤0.01% |
6,600
-4,500
| -41% | -$12.6K |
2021 Q3
13 quarters
|
|
13246
Hongli Group
HLP
$188M
| $16.9K | ﹤0.01% |
+12,867
| New | +$16.5K |
2024 Q4
0 quarters
|
|
|
AL
13247
DELISTED
Air Lease Corp
AL
| $16.8K | ﹤0.01% |
348
| – | – |
2022 Q1
11 quarters
|
|
13248
PUT
BGSF Inc
BGSF
$50.7M
| $16.8K | ﹤0.01% |
3,200
+2,600
| +433% | +$17.9K |
2024 Q2
2 quarters
|
|
|
FMST
13249
Foremost Lithium Resource & Technology
FMST
$9.05M
| $16.8K | ﹤0.01% |
+11,892
| New | +$23.8K |
2024 Q4
0 quarters
|
|
13250
CALL
NetSol Technologies
NTWK
$73.6M
| $16.8K | ﹤0.01% |
6,400
+5,200
| +433% | +$14.9K |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.